IBD5 polymorphisms in inflammatory bowel disease: Association with response to infliximab

doi:10.3748/wjg.v11.i8.1187

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3002)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-3) series.

Item

Count

PDF

338

HTML

2435

Tables (1-3)

229

Sum=3002

Feb 28, 2005 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (59)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Feb 28, 2005; 11(8): 1187-1192
Published online Feb 28, 2005. doi: 10.3748/wjg.v11.i8.1187

IBD5 polymorphisms in inflammatory bowel disease: Association with response to infliximab

Elena Urcelay, Juan Luis Mendoza, Alfonso Martínez, Laura Fernández, Carlos Taxonera, Manuel Díaz-Rubio, Emilio G. de la Concha

Elena Urcelay, Alfonso Martínez, Laura Fernández, Emilio G. de la Concha, Immunology Department, Hospital Universitario San Carlos, Madrid, Spain

Juan Luis Mendoza, Carlos Taxonera, Manuel Díaz-Rubio, Gastroenterology Department, Hospital Universitario San Carlos, Madrid, Spain

Author contributions: All authors contributed equally to the work.

Correspondence to: Dr. Elena Urcelay, Immunology Department, Hospital Universitario San Carlos, Martin Lagos s/n, Madrid 28040, Spain. eurcelay@hcsc.es

Telephone: +34-913303347 Fax: +34-913303344

Received: September 7, 2004
Revised: September 9, 2004
Accepted: October 27, 2004
Published online: February 28, 2005

Core Tip